CancerNetwork®’s podcast hosted 2 experts to discuss the current state of biosimilar prescriptions and the need for change to improve the system overall.
Michael Kane, RPh, BCOP
Advertisement
Articles by Michael Kane, RPh, BCOP
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
Toxicity From CD19, BCMA Therapy May Inform B-Cell Malignancy Surveillance
2
Sac-TMT Significantly Improves PFS/OS in Pretreated Endometrial Cancer
3
Nogapendekin Alfa Plus BCG Exhibits Efficacy Advantage in NMIBC In Situ
4
Fianlimab Combo Does Not Significantly Improve PFS in Advanced Melanoma
5